CVS Health Corp. buy Barclays PLC
Summary
This prediction ended on 03.06.26 with a price of €76.84. The BUY prediction by Barclays_PLC for CVS Health Corp. saw massive gains of 38.60%. Barclays_PLC has a follow-up prediction for CVS Health Corp. where he still thinks CVS Health Corp. is a Buy. Barclays_PLC has 50% into this predictionCVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| CVS Health Corp. | 9.280% | 9.280% | 50.036% |
| iShares Core DAX® | -2,49 % | 0,32 % | 0,75 % |
| iShares Nasdaq 100 | -4,40 % | 1,59 % | 32,09 % |
| iShares Nikkei 225® | -4,29 % | 0,97 % | 50,00 % |
| iShares S&P 500 | -2,20 % | 2,00 % | 22,60 % |
Comments by Barclays_PLC for this prediction
In the thread CVS Health Corp. diskutieren
In the thread Trading CVS Health Corp.